Proteomic analysis of changes in protein expression in liver mitochondria in apoE knockout mice

Journal of Proteomics

Volumn 74, Issue 6, 2011, Pages 887-893

  Suski, Maciej ^a   Olszanecki, Rafał ^a   Madej, Józef ^a   Totoń Zurańska, Justyna ^a   Niepsuj, Anna ^a   Jawień, Jacek ^a   Bujak Gizycka, Beata ^a   Okoń, Krzysztof ^a   Korbut, Ryszard ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Apolipoprotein E; Glyoxalase; Liver; Major urinary protein; Mitochondria; Proteomics

Indexed keywords

APOLIPOPROTEIN E; MITOCHONDRIAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; FATTY LIVER; FEMALE; FUNCTIONAL PROTEOMICS; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN DEFICIENCY; LIQUID CHROMATOGRAPHY; LIVER MITOCHONDRION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; APOLIPOPROTEINS E; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; PROTEOME; PROTEOMICS;

MUS;

EID: 79955471129     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.03.003     Document Type: Article

References (30)

1. Newman T.C., Dawson P.A., Rudel L.L., Williams D.L. Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. J Biol Chem 1985, 260(4):2452-2457.
2. Greenow K., Pearce N.J., Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J Mol Med 2005, 83(5):329-342.
3. Bonomini F., Filippini F., Hayek T., Aviram M., Rezzani R. Apolipoprotein E and its role in aging and survival. Exp Gerontol 2010, 45(2):149-157.
4. Newmeyer D.D., Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003, 112(4):481-490.
5. Mantena S.K., King A.L., Andringa K.K., Eccleston H.B., Bailey S.M. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 2008, 44(7):1259-1272.
6. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106(5):544-549.
7. Wei Y., Rector R.S., Thyfault J.P., Ibdah J.A. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008, 14(2):193-199.
8. Nakamura T., Watanabe A., Fujino T., Hosono T., Michikawa M. Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol Neurodegener 2009, 4:35. %20.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
10. Yan J.X., Wait R., Berkelman T., Harry R.A., Westbrook J.A., Wheeler C.H., et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21(17):3666-3672.
11. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1(6):2856-2860.
12. Alaynick W.A. Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion 2008, 8(4):329-337.
13. Guillen N., Navarro M.A., Arnal C., Noone E., Arbones-Mainar J.M., Acin S., et al. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol Genomics 2009, 37(3):187-198.
14. Chamero P., Marton T.F., Logan D.W., Flanagan K., Cruz J.R., Saghatelian A., et al. Identification of protein pheromones that promote aggressive behaviour. Nature 2007, 450(7171):899-902.
15. Hui X., Zhu W., Wang Y., Lam K.S., Zhang J., Wu D., et al. Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. J Biol Chem 2009, 284(21):14050-14057.
16. Zhou Y., Jiang L., Rui L. Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J Biol Chem 2009, 284(17):11152-11159.
17. Marasinghe G.P., Sander I.M., Bennett B., Periyannan G., Yang K.W., Makaroff C.A., et al. Structural studies on a mitochondrial glyoxalase II. J Biol Chem 2005, 280(49):40668-40675.
18. Dmitriev L.F., Titov V.N. Lipid peroxidation in relation to ageing and the role of endogenous aldehydes in diabetes and other age-related diseases. Ageing Res Rev 2010, 9(2):200-210.
19. Thornalley P.J. Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003, 31(Pt 6):1343-1348.
20. Creighton D.J., Zheng Z.B., Holewinski R., Hamilton D.S., Eiseman J.L. Glyoxalase I inhibitors in cancer chemotherapy. Biochem Soc Trans 2003, 31(Pt 6):1378-1382.
21. Yesilova Z., Yaman H., Oktenli C., Ozcan A., Uygun A., Cakir E., et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2005, 100(4):850-855.
22. Torzewski M., Ochsenhirt V., Kleschyov A.L., Oelze M., Daiber A., Li H., et al. Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27(4):850-857.
23. Cox A.G., Winterbourn C.C., Hampton M.B. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 2009, 425(2):313-325.
24. Petrosillo G., Portincasa P., Grattagliano I., Casanova G., Matera M., Ruggiero F.M., et al. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta 2007, 1767(10):1260-1267.
25. Mehta K., Van Thiel D.H., Shah N., Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002, 60(9):289-293.
26. Joy B., Sivadasan R., Abraham T.E., John M., Sobhan P.K., Seervi M., et al. Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis. Mol Carcinog 2010, 49(4):324-336.
27. Muntener K., Zwicky R., Csucs G., Rohrer J., Baici A. Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death. J Biol Chem 2004, 279(39):41012-41017.
28. Baskin-Bey E.S., Canbay A., Bronk S.F., Werneburg N., Guicciardi M.E., Nyberg S.L., et al. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2005, 288(2):G396-G402.
29. Li Z., Berk M., McIntyre T.M., Gores G.J., Feldstein A.E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 2008, 47(5):1495-1503.
30. Crouser E.D., Julian M.W., Huff J.E., Struck J., Cook C.H. Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 2006, 34(9):2439-2446.